Adhesin

	WikiDoc Resources for Adhesin
Articles
Most recent articles on Adhesin Most cited articles on Adhesin Review articles on Adhesin Articles on Adhesin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Adhesin Images of Adhesin Photos of Adhesin Podcasts & MP3s on Adhesin Videos on Adhesin
Evidence Based Medicine
Cochrane Collaboration on Adhesin Bandolier on Adhesin TRIP on Adhesin
Clinical Trials
Ongoing Trials on Adhesin at Clinical Trials.gov Trial results on Adhesin Clinical Trials on Adhesin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Adhesin NICE Guidance on Adhesin NHS PRODIGY Guidance FDA on Adhesin CDC on Adhesin
Books
Books on Adhesin
News
Adhesin in the news Be alerted to news on Adhesin News trends on Adhesin
Commentary
Blogs on Adhesin
Definitions
Definitions of Adhesin
Patient Resources / Community
Patient resources on Adhesin Discussion groups on Adhesin Patient Handouts on Adhesin Directions to Hospitals Treating Adhesin Risk calculators and risk factors for Adhesin
Healthcare Provider Resources
Symptoms of Adhesin Causes & Risk Factors for Adhesin Diagnostic studies for Adhesin Treatment of Adhesin
Continuing Medical Education (CME)
CME Programs on Adhesin
International
Adhesin en Espanol Adhesin en Francais
Business
Adhesin in the Marketplace Patents on Adhesin
Experimental / Informatics
List of terms related to Adhesin

Adherence is often an essential step in bacterial pathogenesis or infection, required for colonizing a new host.^[1] To effectively adhere to host surfaces, many bacteria produce multiple adherence factors called adhesins. For example, nontypeable Haemophilus influenzae expresses the adhesins Hia, Hap, Oap and a hemagglutinating pili.

Adhesins are attractive vaccine candidates because they are often essential to infection and are surface-located, making them readily accessible to antibodies.

The effectiveness of anti-adhesin antibodies is illustrated by studies with FimH, the adhesin of uropathogenic Escherichia coli (UPEC). In animal models, passive immunization with anti FimH-antibodies and vaccination with the protein significantly reduced colonization by UPEC.^[2] Moreover, the Bordetella pertussis adhesins FHA and pertactin are components of 3 of the 4 acellular pertussis vaccines currently licensed for use in the U.S.

References[edit | edit source]

↑ Coutte L, Alonso S, Reveneau N, Willery E, Quatannens B, Locht C, Jacob-Dubuisson F (2003). "Role of adhesin release for mucosal colonization by a bacterial pathogen". J Exp Med. 197 (6): 735–42. PMID 12629063.
↑ Langermann S, Möllby R, Burlein J, Palaszynski S, Auguste C, DeFusco A, Strouse R, Schenerman M, Hultgren S, Pinkner J, Winberg J, Guldevall L, Söderhäll M, Ishikawa K, Normark S, Koenig S (2000). "Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli". J Infect Dis. 181 (2): 774–8. PMID 10669375.

Template:WH Template:WS

[Coutte_2003-1] Coutte L, Alonso S, Reveneau N, Willery E, Quatannens B, Locht C, Jacob-Dubuisson F (2003). "Role of adhesin release for mucosal colonization by a bacterial pathogen". J Exp Med. 197 (6): 735–42. PMID 12629063.

[Langermann_2000-2] Langermann S, Möllby R, Burlein J, Palaszynski S, Auguste C, DeFusco A, Strouse R, Schenerman M, Hultgren S, Pinkner J, Winberg J, Guldevall L, Söderhäll M, Ishikawa K, Normark S, Koenig S (2000). "Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli". J Infect Dis. 181 (2): 774–8. PMID 10669375.

[1]

[2]